SC 13G 1 sch13g_12469k.txt COLLAGENEX PHARMACEUTICALS, INC. SCHEDULE 13G ================================================================================ UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13G (Rule 13d-102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULES 13d-1(b) (c), AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2(b) UNDER THE SECURITIES EXCHANGE ACT OF 1934 (AMENDMENT NO. )* COLLAGENEX PHARMACEUTICALS INC. -------------------------------------------------------------------------------- (Name of Issuer) Common Stock, $0.01 Par Value -------------------------------------------------------------------------------- (Title of Class of Securities) 19419B100 -------------------------------------------------------------------------------- (CUSIP Number) December 31, 2003 -------------------------------------------------------------------------------- (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: [X] Rule 13d-1(b) [ ] Rule 13d-1(c) [ ] Rule 13d-1(d) *The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). ================================================================================ Page 1 of 4 pages =================== =========== CUSIP NO. 19419B100 13G PAGE 2 OF 4 =================== =========== Item 1(a). Name of Issuer: Collagenex Pharmaceuticals Inc. -------------- Item 1(b). Address of Issuer's Principal Executive Offices: ----------------------------------------------- 41 University Drive, Newtown, PA 18940 Item 2(a). Name of Person Filing: Ashford Capital Management, Inc. --------------------- Item 2(b). Address of Principal Business Office or, if None, Residence: ----------------------------------------------------------- P.O. Box 4172, Wilmington, DE 19807 Item 2(c). Citizenship: A Delaware Corporation ----------- Item 2(d). Title of Class of Securities: ---------------------------- Common Stock, $0.01 Par Value Item 2(e). CUSIP Number: 19419B100 ------------ Item 3. If this statement is filed pursuant to Rules 13d-1(b), or 13d-2(b), check whether the person filing is a: ---------------------------------------------- (a) [ ] Broker or Dealer registered under Section 15 of the Securities Exchange Act of 1934 (the "Act"). (b) [ ] Bank as defined in Section 3(a)(6) of the Act. (c) [ ] Insurance Company as defined in Section 3(a)(19) of the Act. (d) [ ] Investment Company registered under Section 8 of the Investment Company Act. (e) [X] Investment Advisor registered under Section 203 of the Investment Advisers Act of 1940. (f) [ ] Employee Benefit Plan, Pension Fund which is subject to the provisions of the Employee Retirement Income Security Act of 1974 or Endowment Fund; see 13d-1(b)(1)(ii)(F). (g) [ ] Parent Holding Company, in accordance with Rule 13d-1(b)(ii)(G); see Item 7. (h) [ ] Group, in accordance with Rule 13d-1(b)(1)(ii)(H). Item 4. Ownership. --------- Not applicable. Item 5. Ownership of Five Percent or Less of a Class. -------------------------------------------- Ashford Capital Management, Inc. has ceased to own beneficially five percent (5%) or more of the outstanding Common Stock of Collagenex Pharmaceuticals, Inc. Item 6. Ownership of More than Five Percent on Behalf of Another Person. ------------------------------------------------ Not applicable. Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person. ------------------------------------------------------------- Not applicable. Item 8. Identification and Classification of Members of the Group. --------------------------------------------------------- Not applicable. Item 9. Notice of Dissolution of Group. ------------------------------ Not applicable. Page 2 of 4 pages =================== =========== CUSIP NO. 19419B100 13G PAGE 3 OF 4 =================== =========== Item 10. Certification. ------------- By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect. Page 3 of 4 pages =================== =========== CUSIP NO. 19419B100 13G PAGE 4 OF 4 =================== =========== SIGNATURE After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. Date: February 10, 2004 ASHFORD CAPITAL MANAGEMENT, INC. By: /s/ Theodore H. Ashford, III ---------------------------- Theodore H. Ashford, III President Page 5 of 5 pages